Source: Headache Medicine. Conference titles: Congresso Brasileiro de Cefaleia. Unidade: FMRP
Subjects: CLOSTRIDIUM, ENXAQUECA, DOR CRÔNICA
ABNT
ROCHA, Ray Almeida da Silva et al. Observational analysis of 12 years-experience with OnabotulinumtoxinA in the treatment of chronic migraine treated in a tertiary headache center. Headache Medicine. Rio de Janeiro: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.48208/HeadacheMed.2023.37.cefaleia. Acesso em: 25 abr. 2026. , 2023APA
Rocha, R. A. da S., Silva, N. de O., Cetlin, R. S., & Dach, F. (2023). Observational analysis of 12 years-experience with OnabotulinumtoxinA in the treatment of chronic migraine treated in a tertiary headache center. Headache Medicine. Rio de Janeiro: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.48208/HeadacheMed.2023.37.cefaleiaNLM
Rocha RA da S, Silva N de O, Cetlin RS, Dach F. Observational analysis of 12 years-experience with OnabotulinumtoxinA in the treatment of chronic migraine treated in a tertiary headache center [Internet]. Headache Medicine. 2023 ; 14( suppl. 2023): 131.[citado 2026 abr. 25 ] Available from: https://doi.org/10.48208/HeadacheMed.2023.37.cefaleiaVancouver
Rocha RA da S, Silva N de O, Cetlin RS, Dach F. Observational analysis of 12 years-experience with OnabotulinumtoxinA in the treatment of chronic migraine treated in a tertiary headache center [Internet]. Headache Medicine. 2023 ; 14( suppl. 2023): 131.[citado 2026 abr. 25 ] Available from: https://doi.org/10.48208/HeadacheMed.2023.37.cefaleia
